Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Oct 5;294(13):1647-54.
doi: 10.1001/jama.294.13.1647.

Clinicopathological features of and risk factors for multiple primary melanomas

Cristina R Ferrone  1 , Leah Ben Porat, Katherine S Panageas, Marianne Berwick, Allan C Halpern, Ami Patel, Daniel G Coit
Affiliations

Clinicopathological features of and risk factors for multiple primary melanomas

Cristina R Ferrone et al. JAMA. .

Abstract

Context: The incidence of multiple primary melanomas ranges from 1.3% to 8.0% in large retrospective reviews; however, the impact of certain risk factors is not understood.

Objectives: To determine the incidence of multiple primary melanomas (MPM) from a prospective, single-institution, multidisciplinary database, and to describe the clinical and pathological characteristics and risk factors specific to these patients.

Design and setting: Review of a prospectively maintained database at Memorial Sloan-Kettering Cancer Center in New York, NY.

Patients: A total of 4484 patients diagnosed with a first primary melanoma between January 1, 1996, and December 31, 2002.

Main outcome measures: Incidence of and risk factors for MPM.

Results: Three hundred eighty-five patients (8.6%) had 2 or more primary melanomas, with an average of 2.3 melanomas per MPM patient. Seventy-eight percent had 2 primary melanomas. For 74% of patients, the initial melanoma was the thickest tumor. Fifty-nine percent presented with their second primary tumor within 1 year. Twenty-one percent of MPM patients had a positive family history of melanoma compared with only 12% of patients with a single primary melanoma (SPM) (P<.001). Thirty-eight percent of MPM patients had dysplastic nevi compared with 18% of SPM patients (P<.001). The estimated cumulative 5-year risk of a second primary tumor for the entire cohort was 11.4%, with almost half of that risk occurring within the first year. For patients with a positive family history or dysplastic nevi, the estimated 5-year risk of MPM was significantly higher at 19.1% and 23.7%, respectively. The most striking increase in incidence for the MPM population was seen for development of a third primary melanoma from the time of second primary melanoma, which was 15.6% at 1 year and 30.9% at 5 years.

Conclusions: The incidence of MPM is increased in patients with a positive family history and/or dysplastic nevi. These patients should undergo intensive dermatologic screening and should consider genetic testing.

PubMed Disclaimer

Comment in

MeSH terms